Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (2): 211-215    DOI: 10.12891/ceog4534.2019
Original Research Previous articles | Next articles
Circulating vaspin and IL-6 concentrations in second trimester pregnancy with gestational diabetes
Y. Huo1, *(), S.-X. Liu1, L. Li1, J. Feng1, H.-Y. Li1, G.-Y. Song2
1Department of Obstetrics & Gynecology, Hebei General Hospital, Shijiazhuang, China;
2Department of Endocrinology, Hebei General Hospital, Shijiazhuang, China
Download:  PDF(203KB)  ( 40 ) Full text   ( 6 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Objective: This study aims to compare serum vaspin and IL-6 concentrations between pregnant women with gestational diabetes mellitus (GDM) and normal glucose tolerance (NGT), as well as with non-pregnant healthy subjects (NC). Materials and Methods: A total of 85 women were included into this study. These patients were divided into groups: GDM group (n=30), patients who had GDM, NGT group, (n=28), pregnant women with normal oral glucose tolerance test (OGTT) values, NC group (n=27), and non-pregnant controls. Vaspin and IL-6 concentrations were measured by enzyme-linked immunosorbent assay (ELISA). Results: Serum vaspin levels did not differ between women with GDM (5.1 ± 2.36 ng/ml) and NGT (5.43 ± 1.88 ng/ml), but were significantly higher than those in the NC group (2.03 ± 2.34 ng/ml, p < 0.01). Circulating vaspin did not significantly correlate with markers of adiposity (BMI) and insulin resistance (fasting plasma glucose, homeostasis model assessment of insulin resistance) in the GDM and NGT groups. However, vaspin was positively correlated to total cholesterol and triglycerides in these two groups, and was significantly negatively correlated with serum IL-6 levels in the GDM group. Conclusions: Serum vaspin concentrations were elevated in pregnant women irrespective of the status of their glucose tolerance. Vaspin may be a marker of lipid metabolism, and may be affected by proinflammatory cytokines such as IL-6 during pregnancy.

Key words:  Gestational diabetes mellitus      Pregnancy      Vaspin      IL-6      Lipid metabolism     
Published:  10 April 2019     
*Corresponding Author(s):  Y. HUO     E-mail:  huoyan_hy@21cn.com

Cite this article: 

Y. Huo, S.-X. Liu, L. Li, J. Feng, H.-Y. Li, G.-Y. Song. Circulating vaspin and IL-6 concentrations in second trimester pregnancy with gestational diabetes. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 211-215.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4534.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I2/211

[1] Ali S. Alqahtani. Seroprevalence of Dengue virus among pregnant mothers and their-newborn infants in the southwest of Saudi Arabia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 741-743.
[2] M. Elmahdy, I. Elfourtia, H. Maghraby. Office hysteroscopy in cases of recurrent implantation failure; Do or not to do[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 723-728.
[3] L.L. Xu, J.Q. Li, Y.Q. Pu, C. Zhou, S.W. Feng, Q. Luo. Effect of prenatal depression during late pregnancy on maternal and neonatal outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 681-686.
[4] Y.X. Wang, M. Zhong, H. Yi, H.F. He. Detection of group B streptococcus colonization in cervical and lower vaginal secretions of pregnant women[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 669-674.
[5] I.F. Urunsak, U.K. Gulec, E. Eser, M. Sucu, C. Akcabay, S. Buyukkurt. The role of dinoprostone for labor induction in postterm and high-risk term pregnancies[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 664-668.
[6] S. Han, S. Choi, S. Nah, Y.H. Lee. Preterm labor in mild carbon monoxide poisoning: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 805-806.
[7] C. Ji, L.J. Sun, L.T. Li, J. Ma, W.H. Ge, X. Zhao. Impact of clinical pharmacist intervention on blood glucose control and perinatal outcomes in gestational diabetes mellitus through a diabetes management system[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 645-652.
[8] H.S.O. Abduljabbar, H. Abduljabar. A systematic review and meta-analysis of the reported symptoms of Covid 19 in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 632-637.
[9] M. Varras, C. Loukas, N. Nikiteas, V.K. Varra, F.N. Varra, E. Georgiou. Comparison of laparoscopic surgical skills acquired on a virtual reality simulator and a box trainer: an analysis for obstetrics-gynecology residents[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 755-763.
[10] H. Yolli, M.E. Demir, R. Yildizhan. Neutrophil gelatinase associated lipocalin-2 (Ngal) levels in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 519-523.
[11] K. Chikazawa, K. Imai, T. Kuwata, K. Takagi. Prophylactic laparoscopic adnexal surgery with low-pressure CO2 insufflation for ovarian cysts during the late first trimester or second trimester of pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 537-540.
[12] J. A. Villarreal-Rodriguez, L. G. Mancillas Adame, J. Maldonado-Sanchez, A. Guzmán-López, O. R. Treviño-Montemayor, J. G. Gonzalez-Gonzalez, D. Saldívar-Rodríguez. A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 552-555.
[13] J. Ogawa, S. Suzuki. Risk factors of self-interruption of medications for mental disorders in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 576-578.
[14] A. Daniilidis, G. Dryllis, G. Chorozoglou, M. Politou, R. Dampali, K. Dinas. Substitution of hemoglobin levels in pregnant women with iron supplement: A prospective randomized clinical study[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 579-583.
[15] Z.Y. Chang, R. Cao, R.C. Xu, Y. Cheng, Q.J. Wan. Pregnancy in a peritoneal dialysis patient undergoing intermittent peritoneal dialysis during the third trimester of pregnancy: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 596-599.
No Suggested Reading articles found!